Catalyst Clinical Research
AcquiredSpecialized multi-therapeutic functional service provider (FSP) and niche oncology CRO for biopharmaceutical and biotechnology companies. Known for expertise in early phase oncology trials.
CEO Nik Morton
Company
Founded
2013
Headquarters
Wilmington, US
Financials
Total Funding
-
Sectors
Funding History
Acquired by Worldwide Clinical Trials Jan 20, 2026
$500M Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.